Literature DB >> 16493502

Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: an example of a significant decrease of treatment costs.

Jose Mateo1, Isabel Badell, Ruth Forner, Montserrat Borrell, Eduardo Tizzano, Jordi Fontcuberta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493502

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

Review 1.  Treatment with rituximab in benign and malignant hematologic disorders in children.

Authors:  Lisa B Giulino; James B Bussel; Ellis J Neufeld
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

Review 2.  Rituximab for treating inhibitors in people with inherited severe hemophilia.

Authors:  Lucan Jiang; Yi Liu; Lingli Zhang; Cristina Santoro; Armando Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-07-07

3.  Rituximab for treating inhibitors in people with inherited severe hemophilia.

Authors:  Lucan Jiang; Yi Liu; Lingli Zhang; Cristina Santoro; Armando Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2020-08-03

4.  Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.

Authors:  C Leissinger; C D Josephson; S Granger; B A Konkle; R Kruse-Jarres; M V Ragni; J M Journeycake; L Valentino; N S Key; J C Gill; K R McCrae; E J Neufeld; C Manno; L Raffini; K Saxena; M Torres; V Marder; C M Bennett; S F Assmann
Journal:  Thromb Haemost       Date:  2014-06-12       Impact factor: 5.249

Review 5.  Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients.

Authors:  Rolf Ljung; Guenter Auerswald; Gary Benson; Gerry Dolan; Anne Duffy; Cedric Hermans; Victor Jiménez-Yuste; Thierry Lambert; Massimo Morfini; Silva Zupančić-Šalek; Elena Santagostino
Journal:  Eur J Haematol       Date:  2018-12-06       Impact factor: 2.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.